{"version":"https://jsonfeed.org/version/1","title":"The Canadian Children Inflammatory Bowel Disease Network","home_page_url":"https://ccibdn.ca","description":"The Canadian Children Inflammatory Bowel Disease Network","author":{"name":"The Canadian Children Inflammatory Bowel Disease Network"},"items":[{"id":"https://ccibdn.ca/blog/f/ccibdn-summit-2026---first-meeting-of-its-kind","html_content":"

","url":"https://ccibdn.ca/blog/f/ccibdn-summit-2026---first-meeting-of-its-kind","title":"CCIBDN Summit 2026 - first meeting of its kind ","date_modified":"2026-07-16T18:44:38Z"},{"id":"https://ccibdn.ca/blog/f/early-drug-monitoring-helps-fine-tune-ustekinumab-dosing","html_content":"

OUR AIM - Previous studies suggested that some smaller children may not be receiving enough medication with standard weight-based dosing. We wanted to test whether smaller kids who weigh less need a different dose per kg...

","url":"https://ccibdn.ca/blog/f/early-drug-monitoring-helps-fine-tune-ustekinumab-dosing","title":"Early drug monitoring helps fine-tune Ustekinumab dosing","summary":"OUR AIM - Previous studies suggested that some smaller children may not be receiving enough medication with standard weight-based dosing. We wanted to test whether smaller kids who weigh less need a different dose per kg...","date_modified":"2026-06-16T15:35:10Z"},{"id":"https://ccibdn.ca/blog/f/parental-perspectives-important-in-transition-to-adult-care","html_content":"

BACKGROUND – The experiences of parents remain markedly underexplored, despite their potential to be positioned as a critical resource for promoting successful transition to adult care, and mitigating transition-related ...

","url":"https://ccibdn.ca/blog/f/parental-perspectives-important-in-transition-to-adult-care","title":"Parental perspectives important in transition to adult care","summary":"BACKGROUND – The experiences of parents remain markedly underexplored, despite their potential to be positioned as a critical resource for promoting successful transition to adult care, and mitigating transition-related ...","date_modified":"2026-03-27T16:56:25Z"},{"id":"https://ccibdn.ca/blog/f/ccibdn-2025-highlights","html_content":"

These highlights are from the Year Four Report submitted to the CH.I.L.D. Foundation. We encourage members to read the full report for more detailed information.

","url":"https://ccibdn.ca/blog/f/ccibdn-2025-highlights","title":"CCIBDN 2025 Highlights ","summary":"These highlights are from the Year Four Report submitted to the CH.I.L.D. Foundation. We encourage members to read the full report for more detailed information.","date_modified":"2026-03-27T16:30:20Z"},{"id":"https://ccibdn.ca/blog/f/predicting-costs-in-childhood-ibd","html_content":"

BACKGROUND - The incidence of pediatric-onset inflammatory bowel disease (IBD) and the costs of caring for individuals with IBD are both increasing.

","url":"https://ccibdn.ca/blog/f/predicting-costs-in-childhood-ibd","title":"Predicting costs in childhood IBD","summary":"BACKGROUND - The incidence of pediatric-onset inflammatory bowel disease (IBD) and the costs of caring for individuals with IBD are both increasing. ","date_modified":"2025-08-26T17:05:21Z"},{"id":"https://ccibdn.ca/blog/f/cidscann-members-received-awards-at-cddw-2025","html_content":"

The following CIDsCaNN members received awards at CDDW (the annual meeting of Canadian Association of Gastroenterology):   

","url":"https://ccibdn.ca/blog/f/cidscann-members-received-awards-at-cddw-2025","title":"CIDsCaNN members received awards at CDDW (2025)","summary":"The following CIDsCaNN members received awards at CDDW (the annual meeting of Canadian Association of Gastroenterology):   ","date_modified":"2025-06-09T22:23:37Z"},{"id":"https://ccibdn.ca/blog/f/cidscann-members-honoured-with-triangle-awards-2025","html_content":"

TRIANGLE Awards have been developed at all levels of training to increase the capacity for benchmark research in GI and liver research across Canada. Congratulation to the following CIDsCaNN members!

","url":"https://ccibdn.ca/blog/f/cidscann-members-honoured-with-triangle-awards-2025","title":"CIDsCaNN Members honoured with TRIANGLE Awards (2025)","summary":"TRIANGLE Awards have been developed at all levels of training to increase the capacity for benchmark research in GI and liver research across Canada. Congratulation to the following CIDsCaNN members! ","date_modified":"2025-05-20T17:48:20Z"},{"id":"https://ccibdn.ca/blog/f/a-simple-blood-helps-predict-disease-severity-in-kids-with-ibd","html_content":"

OUR AIM was primarily to investigate the relationship between NLR and how severe the disease looks during endoscopy in kids with IBD. We also examined whether NLR predicted hospitalization, surgery, and therapy response ...

","url":"https://ccibdn.ca/blog/f/a-simple-blood-helps-predict-disease-severity-in-kids-with-ibd","title":"Simple Blood Test Helps Predict Disease Severity in Kids with IBD","summary":"OUR AIM was primarily to investigate the relationship between NLR and how severe the disease looks during endoscopy in kids with IBD. We also examined whether NLR predicted hospitalization, surgery, and therapy response ...","date_modified":"2025-05-12T16:35:35Z"},{"id":"https://ccibdn.ca/blog/f/ai-algorithm-helps-tailor-medical-treatments-after-pcd-diagnosis","html_content":"

OUR AIM was to apply machine learning (artificial intelligence) to predict the probability of first bowel resection over future time on novel pediatric Crohn’s disease (pCD) patients.

","url":"https://ccibdn.ca/blog/f/ai-algorithm-helps-tailor-medical-treatments-after-pcd-diagnosis","title":"AI algorithm helps tailor medical treatments after pCD diagnosis ","summary":"OUR AIM was to apply machine learning (artificial intelligence) to predict the probability of first bowel resection over future time on novel pediatric Crohn’s disease (pCD) patients.","date_modified":"2025-04-01T19:50:10Z"},{"id":"https://ccibdn.ca/blog/f/cidscann-2024-highlights","html_content":"

These highlights are from the Year Three Report submitted to ChILD. We encourage members to read the full report for more detailed information.

","url":"https://ccibdn.ca/blog/f/cidscann-2024-highlights","title":"CIDsCaNN 2024 Highlights","summary":"These highlights are from the Year Three Report submitted to ChILD. We encourage members to read the full report for more detailed information.","date_modified":"2025-03-24T21:38:30Z"},{"id":"https://ccibdn.ca/blog/f/ipeer2peer-program-helps-fill-gap-in-holistic-ibd-care-for-teens","html_content":"

Many chronic diseases, like IBD, are long-lasting conditions that can cause feelings of isolation because they are often invisible on the outside. This can make it hard for children and teens to participate in activities...

","url":"https://ccibdn.ca/blog/f/ipeer2peer-program-helps-fill-gap-in-holistic-ibd-care-for-teens","title":"iPeer2Peer program helps fill gap in holistic IBD care for teens","summary":"Many chronic diseases, like IBD, are long-lasting conditions that can cause feelings of isolation because they are often invisible on the outside. This can make it hard for children and teens to participate in activities...","date_modified":"2024-11-01T18:44:06Z"},{"id":"https://ccibdn.ca/blog/f/cidscann-letter-to-the-us-fda","html_content":"

The following is a summary of the response from CIDsCaNN to the US Food and Drug Administration (FDA) Draft Guidance for Industry on pediatric inflammatory bowel disease: developing drugs for treatment. The full letter h...

","url":"https://ccibdn.ca/blog/f/cidscann-letter-to-the-us-fda","title":"CIDsCaNN letter to the US FDA ","summary":"The following is a summary of the response from CIDsCaNN to the US Food and Drug Administration (FDA) Draft Guidance for Industry on pediatric inflammatory bowel disease: developing drugs for treatment. The full letter h...","date_modified":"2024-10-17T14:43:18Z"},{"id":"https://ccibdn.ca/blog/f/dr-eytan-wine-on-the-bowel-sounds-podcast","html_content":"

Tune in to listen to CIDsCaNN's Dr. Eytan Wine discuss dietary approaches to treating patients with Crohn's Disease, in an episode of the podcast, Bowel Sounds, hosted by Drs. Jennifer Lee and Jason Silverman. They talk ...

","url":"https://ccibdn.ca/blog/f/dr-eytan-wine-on-the-bowel-sounds-podcast","title":"Dr. Eytan Wine on the Bowel Sounds Podcast","summary":"Tune in to listen to CIDsCaNN's Dr. Eytan Wine discuss dietary approaches to treating patients with Crohn's Disease, in an episode of the podcast, Bowel Sounds, hosted by Drs. Jennifer Lee and Jason Silverman. They talk ...","date_modified":"2024-07-15T22:26:34Z"},{"id":"https://ccibdn.ca/blog/f/pre-diagnosis-diet-can-predict-response-to-een-therapy-in-cd","html_content":"

OUR AIM was to determine whether a child’s diet prior to a diagnosis of Crohn Disease (CD) could establish a baseline intestinal microbiome, which influences their response to Exclusive Enteral Nutrition (EEN) formula-ba...

","url":"https://ccibdn.ca/blog/f/pre-diagnosis-diet-can-predict-response-to-een-therapy-in-cd","title":"Pre-diagnosis diet can predict response to EEN therapy in CD","summary":"OUR AIM was to determine whether a child’s diet prior to a diagnosis of Crohn Disease (CD) could establish a baseline intestinal microbiome, which influences their response to Exclusive Enteral Nutrition (EEN) formula-ba...","date_modified":"2024-04-19T18:04:42Z"},{"id":"https://ccibdn.ca/blog/f/cidscann-2023-highlights","html_content":"

The highlights are taken from the Year Two Report, prepared for the C.H.I.L.D Foundation. Members are encouraged to read the full report for more detailed information.

","url":"https://ccibdn.ca/blog/f/cidscann-2023-highlights","title":"CIDsCaNN 2023 Highlights","summary":"The highlights are taken from the Year Two Report, prepared for the C.H.I.L.D Foundation. Members are encouraged to read the full report for more detailed information.","date_modified":"2024-04-07T21:23:39Z"},{"id":"https://ccibdn.ca/blog/f/adalimumab-vs-inflixumab-improved-outcomes-at-one-year","html_content":"

Our aim was to compare real-world effectiveness between commonly prescribed medications adalimumab (ADA) and infliximab (IFX) in children with luminal Crohn’s disease (CD).

","url":"https://ccibdn.ca/blog/f/adalimumab-vs-inflixumab-improved-outcomes-at-one-year","title":"Adalimumab vs Inflixumab: Improved Outcomes at One Year","summary":"Our aim was to compare real-world effectiveness between commonly prescribed medications adalimumab (ADA) and infliximab (IFX) in children with luminal Crohn’s disease (CD). ","date_modified":"2024-02-05T19:00:00Z"},{"id":"https://ccibdn.ca/blog/f/outcomes-following-acute-severe-colitis-at-initial-presentation","html_content":"

Our aim was to assess outcomes in children with acute severe ulcerative colitis (ASUC) at initial presentation.

","url":"https://ccibdn.ca/blog/f/outcomes-following-acute-severe-colitis-at-initial-presentation","title":"Outcomes Following Acute Severe Colitis at Initial Presentation","summary":"Our aim was to assess outcomes in children with acute severe ulcerative colitis (ASUC) at initial presentation. ","date_modified":"2024-02-05T19:00:00Z"},{"id":"https://ccibdn.ca/blog/f/cidscann-2022-highlights","html_content":"

The highlights are taken from the Year One Report, prepared for the C.H.I.L.D Foundation. Members are encouraged to read the full report for more detailed information.

","url":"https://ccibdn.ca/blog/f/cidscann-2022-highlights","title":"CIDsCaNN 2022 Highlights","summary":"The highlights are taken from the Year One Report, prepared for the C.H.I.L.D Foundation. Members are encouraged to read the full report for more detailed information.","date_modified":"2023-11-29T19:42:56Z"},{"id":"https://ccibdn.ca/blog/f/study-shows-ethnicity-is-important-factor-in-childhood-ibd","html_content":"

The aim of this CIDsCaNN study was to examine ancestry and subtype variations of Canadian children newly diagnosed with Inflammatory Bowel Disease (IBD).

","url":"https://ccibdn.ca/blog/f/study-shows-ethnicity-is-important-factor-in-childhood-ibd","title":"Study shows ethnicity is important consideration in childhood IBD","summary":"The aim of this CIDsCaNN study was to examine ancestry and subtype variations of Canadian children newly diagnosed with Inflammatory Bowel Disease (IBD).","date_modified":"2023-11-29T19:18:22Z"},{"id":"https://ccibdn.ca/blog/f/utekinumab-shows-promise-in-children-with-ulcerative-colitis","html_content":"

The aim: The purpose of this CIDsCaNN study was to examine the effectiveness of ustekinumab therapy for treating ulcerative colitis (UC) in children.

","url":"https://ccibdn.ca/blog/f/utekinumab-shows-promise-in-children-with-ulcerative-colitis","title":"Ustekinumab proves effective for children with ulcerative colitis","summary":"The aim: The purpose of this CIDsCaNN study was to examine the effectiveness of ustekinumab therapy for treating ulcerative colitis (UC) in children. ","date_modified":"2023-11-28T16:58:36Z"}]}